Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2025-12-26 @ 1:29 PM
Study NCT ID:
NCT01392495
Status:
TERMINATED
Last Update Posted:
2015-08-10
First Post:
2011-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-06
Start Date Type:
None
Primary Completion Date:
2014-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-11
First Submit QC Date:
None
Study First Post Date:
2011-07-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-03-24
Results First Submit QC Date:
None
Results First Post Date:
2015-07-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-07-13
Last Update Post Date:
2015-08-10
Last Update Post Date Type:
ESTIMATED